Clinical Study Results
1. Study Name
Title of the study: A Randomized, Double-Blind, Multicenter Study of
Denosumab Compared With Zoledronic Acid in the
Treatment of Bone Disease in Subjects With Newly
Diagnosed Multiple Myeloma
Brief Title: Denosumab Compared to Zoledronic Acid in the Treatment
of Bone Disease in Patients With Multiple Myeloma
Protocol Number: 20090482
EU Trial Number: 2010-020454-34
Other Identifiers: NCT01345019 (Clinicaltrials.gov identifier)
Date of This 25 November 2020
Summary:
What does this summary cover?
This summary shows the main results from one clinical study. The results are only
for this study. Other studies may find different results. Researchers and health
authorities look at the results of many studies to decide which medicines work best
and are safest for patients.
Amgen has committed to make research results available to the public. This
summary has been provided as part of that commitment and should not be used for
any other purpose. It should not be considered to make a claim for any product or to
guide treatment decisions.
Some information in this summary may be different from the approved labelling for
denosumab. Your healthcare professional should refer to the full prescribing
information for proper use of denosumab.
1